Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 1, Pages 138
Publisher
MDPI AG
Online
2022-12-27
DOI
10.3390/cancers15010138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and characterization of post-translational modifications: Clinical implications
- (2022) Juliane Hermann et al. MOLECULAR ASPECTS OF MEDICINE
- Lysine Acetylation, Cancer Hallmarks and Emerging Onco-Therapeutic Opportunities
- (2022) Meilan Hu et al. Cancers
- Recent developments of HDAC inhibitors: Emerging indications and novel molecules
- (2021) Andrey D. Bondarev et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer Vaccines, Adjuvants, and Delivery Systems
- (2021) Samantha J. Paston et al. Frontiers in Immunology
- A current view on Tau protein phosphorylation in Alzheimer's disease
- (2021) Susanne Wegmann et al. CURRENT OPINION IN NEUROBIOLOGY
- Protein citrullination as a source of cancer neoantigens
- (2021) Hiroyuki Katayama et al. Journal for ImmunoTherapy of Cancer
- HDAC inhibitors: Targets for tumor therapy, immune modulation and lung diseases
- (2021) Geetha Shanmugam et al. Translational Oncology
- Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses
- (2021) Peter Symonds et al. Frontiers in Immunology
- Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer
- (2020) Mizuho Ohara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Post-translational modifications such as citrullination are excellent targets for cancer therapy
- (2020) V.A. Brentville et al. SEMINARS IN IMMUNOLOGY
- MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
- (2020) Victor H Engelhard et al. Journal for ImmunoTherapy of Cancer
- Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
- (2020) Sebastian P. Haen et al. Nature Reviews Clinical Oncology
- Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
- (2020) Victoria A Brentville et al. Journal for ImmunoTherapy of Cancer
- Novel molecular targets in gastric adenocarcinoma
- (2020) Roya Ramezankhani et al. PHARMACOLOGY & THERAPEUTICS
- Dysregulation of phosphoproteins in hepatocellular carcinoma revealed via quantitative analysis of the phosphoproteome
- (2020) Yixian Liu et al. Oncology Letters
- Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives
- (2019) Danielle Q Calcagno et al. Epigenomics
- Turning the corner on therapeutic cancer vaccines
- (2019) Robert E. Hollingsworth et al. npj Vaccines
- T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy
- (2019) Victoria A Brentville et al. OncoImmunology
- Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma
- (2019) Taewoo Yang et al. Canadian Journal of Gastroenterology and Hepatology
- Citrullination in Cancer
- (2019) Arseniy E. Yuzhalin CANCER RESEARCH
- The function of histone acetylation in cervical cancer development
- (2019) Shanshan Liu et al. BIOSCIENCE REPORTS
- Protein glycosylation
- (2019) Jerry Eichler CURRENT BIOLOGY
- The global pipeline of cell therapies for cancer
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
- (2019) Stefan Mereiter et al. CANCER CELL
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders
- (2019) Mohammed Alghamdi et al. Journal of Immunology Research
- Rheumatoid arthritis and citrullination
- (2018) Erika Darrah et al. CURRENT OPINION IN RHEUMATOLOGY
- The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications
- (2018) Pingping Guo et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2018) Chao Li et al. Gastroenterology Research and Practice
- Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma
- (2018) Kenzo Ohara et al. OncoImmunology
- Histone deacetylase 6 in cancer
- (2018) Ting Li et al. Journal of Hematology & Oncology
- Investigation of post-translational modifications in type 2 diabetes
- (2018) Bhaswati Chatterjee et al. Clinical Proteomics
- Mucin 2 (MUC2) modulates the aggressiveness of breast cancer
- (2018) Anna Astashchanka et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation-Induced Citrullinated Glucose-Regulated Protein 78 Elicits Immune Responses in Human Type 1 Diabetes
- (2018) Mijke Buitinga et al. DIABETES
- Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection
- (2017) Renée Turzanski Fortner et al. GYNECOLOGIC ONCOLOGY
- Citrullinated α-enolase is an effective target for anti-cancer immunity
- (2017) Katherine Cook et al. OncoImmunology
- Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
- (2017) Caroline Tosch et al. Journal for ImmunoTherapy of Cancer
- A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas
- (2016) W. Fiedler et al. EUROPEAN JOURNAL OF CANCER
- Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
- (2016) Avery D. Posey et al. IMMUNITY
- TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
- (2016) Elisabeth Quoix et al. LANCET ONCOLOGY
- A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens
- (2016) Adán Alpízar et al. MOLECULAR & CELLULAR PROTEOMICS
- Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology
- (2016) Lei Yang et al. NEUROCHEMICAL RESEARCH
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer
- (2016) E. Scheid et al. Cancer Immunology Research
- Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
- (2016) H. J. Gray et al. Journal for ImmunoTherapy of Cancer
- Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
- (2015) V. A. Brentville et al. CANCER RESEARCH
- Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation
- (2015) Michela Capello et al. IMMUNOLOGY LETTERS
- Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications
- (2015) Imayavaramban Lakshmanan et al. Journal of Thoracic Oncology
- The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
- (2015) Elizabeth S. Gabitzsch et al. Oncotarget
- Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
- (2015) Alan Kirwan et al. Biomed Research International
- Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer
- (2015) Christopher R. Heery et al. JAMA Oncology
- Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment
- (2014) Lazaros I. Sakkas et al. AUTOIMMUNITY REVIEWS
- Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
- (2014) Takumi Kumai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer
- (2014) A. L. Zarling et al. CANCER RESEARCH
- 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
- (2014) Eric Verdin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The growing landscape of lysine acetylation links metabolism and cell signalling
- (2014) Chunaram Choudhary et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer
- (2014) Paul LR Mitchell et al. Journal for ImmunoTherapy of Cancer
- Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
- (2013) Di Zhao et al. CANCER CELL
- Serologic Autoantibodies as Diagnostic Cancer Biomarkers--A Review
- (2013) P. Zaenker et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Glyceraldehyde-3-phosphate Dehydrogenase Is Activated by Lysine 254 Acetylation in Response to Glucose Signal
- (2013) Tingting Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- Mitogenic and Oncogenic Stimulation of K433 Acetylation Promotes PKM2 Protein Kinase Activity and Nuclear Localization
- (2013) Lei Lv et al. MOLECULAR CELL
- Early in vivo signaling profiles in MUC1-specific CD4+T cells responding to two different MUC1-targeting vaccines in two different microenvironments
- (2013) Dawn K. Reichenbach et al. OncoImmunology
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- TG4010
- (2012) Jean-Marc Limacher et al. OncoImmunology
- MUC2 Is a Highly Specific Marker of Goblet Cell Metaplasia in the Distal Esophagus and Gastroesophageal Junction
- (2011) Maria G. McIntire et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer
- (2011) Yi-Long Wu et al. BMC CANCER
- A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
- (2011) M. Mohebtash et al. CLINICAL CANCER RESEARCH
- α-enolase: a promising therapeutic and diagnostic tumor target
- (2011) Michela Capello et al. FEBS Journal
- Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells
- (2011) Hiroo Hasegawa et al. LEUKEMIA & LYMPHOMA
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Vaccine against MUC1 Antigen Expressed in Inflammatory Bowel Disease and Cancer Lessens Colonic Inflammation and Prevents Progression to Colitis-Associated Colon Cancer
- (2010) P. L. Beatty et al. Cancer Prevention Research
- Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells
- (2010) H Akbulut et al. GENE THERAPY
- Structural Basis for the Presentation of Tumor-Associated MHC Class II-Restricted Phosphopeptides to CD4+ T Cells
- (2010) Yili Li et al. JOURNAL OF MOLECULAR BIOLOGY
- Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
- (2010) Weidong Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Circulating Autoantibodies to Phosphorylated α-Enolase are a Hallmark of Pancreatic Cancer
- (2010) Barbara Tomaino et al. JOURNAL OF PROTEOME RESEARCH
- YAP dysregulation by phosphorylation or ΔNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets
- (2010) R Ehsanian et al. ONCOGENE
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
- Post-translationally modified T cell epitopes: immune recognition and immunotherapy
- (2009) Jan Petersen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
- (2009) F. R. Depontieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes
- (2009) Jan Petersen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma
- (2008) J. L. Gulley et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now